Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

- 1 min read

Bicara Therapeutics Announces $108M Series B Financing to Advance Dual-Action Biologics for Cancer

Cambridge, MA, March 6, 2023 (Business Wire) -- Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable anti-tumor response, today announced that it completed an oversubscribed $108 million Series B financing to advance its lead program BCA101 and its pipeline of investigational candidates to treat solid tumor cancers.

Read full article here.

Recent Posts

See All

Enovis Announces Acquisition of LimaCorporate, a Surgical Implants Manufacturer, in $850M Deal

Wilmington, DE, September 25, 2023 (Reuters) -- Enovis Corp (ENOV.N), a leader in orthopedic bracing, surgical implants, and footcare solutions, announced on Monday its strategic acquisition of Lima

Protaryx Medical Welcomes David Mester as New CEO to Spearhead Advancements

Baltimore, MD, September 12, 2023 (Business Wire) -- Protaryx Medical, announces, David Mester, MBA, as its newly appointed Chief Executive Officer (CEO). With a remarkable career spanning more tha

Takeda Invests $580M in AcuraStem's ALS Treatments, Forges License Agreement to Advance PIKFY

Monrovia, CA, September 25, 2023 (PRNewswire) -- AcuraStem, a patient-based biotechnology company pioneering how treatments are developed for neurodegenerative diseases, announced today that it has

Enovis Announces Acquisition of LimaCorporate, a Surgical Implants Manufacturer, in $850M Deal

Protaryx Medical Welcomes David Mester as New CEO to Spearhead Advancements

Takeda Invests $580M in AcuraStem's ALS Treatments, Forges License Agreement to Advance PIKFY

Madrigal Appoints Sanofi's Bill Sibold as CEO

Boston Scientific Acquires Relievant Medsystems in $850M Deal for Chronic Pain Therapy

Ibex Medical Analytics Secures $55M in Series C Round

Illumina's Appoints Jacob Thaysen, Ph.D. as its New CEO

Apollo Therapeutics Secures $226.5M in Series C Funding

Leadership Changes at Orthofix Medical Inc. as Catherine Burzik Assumes Interim CEO Role

Immatics NV and Moderna Forge Billion-Dollar Collaboration to Revolutionize Cancer Therapy

Executive Spotlights

Bicara Therapeutics Announces $108M Series B Financing to Advance Dual-Action Biologics for Cancer

Recent Posts

Life Science Headlines